Synthesis and in vitro studies of biodegradable modified chitosan nanoparticles for photodynamic treatment of cancer

International Journal of Biological Macromolecules

Volumn 49, Issue 5, 2011, Pages 1059-1065

  Reza Saboktakin, Mohammad ^a,b   Tabatabaie, Roya M ^a   Maharramov, Abel ^b   Ali Ramazanov, Mohammad ^b  

^a International Research Institute of Arian Chemie Gostar   (Iran)

^b BAKU STATE UNIVERSITY   (Azerbaijan)

Author keywords

Biodegradable; Cancer; In vitro; Modified chitosan; Photodynamic

Indexed keywords

CHITOSAN DERIVATIVE; N SULFONATO N,O CARBOXYMETHYLCHITOSAN; N,N' METHYLENEBISACRYLAMIDE; NANOPARTICLE; POLYMETHACRYLIC ACID; TEMOPORFIN; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CANCER THERAPY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STRUCTURE; IN VITRO STUDY; MOLECULAR STABILITY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; POLYMERIZATION; THERMODYNAMICS; X RAY DIFFRACTION;

EID: 80054860514     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2011.08.031     Document Type: Article

References (20)

1. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., Peng Q. J. Natl. Cancer Inst. 1998, 90:889-905.
2. Dolmans D.E., Fukumura D., Jain R.K. Nat. Rev. Cancer 2003, 3:380-387.
3. Bonnett R. Chem. Soc. Rev. 1995, 24:19-33.
4. Moore C.M., Nathan T.R., Lees W.R., Mosse C.A., Freeman A., Emberton M., Bown S.G. Lasers Surg. Med. 2006, 38:356-363.
5. Hopper C., Kubler A., Lewis H., Tan I.B., Putnam G. Int. J. Cancer 2004, 111:138-146.
6. Friedberg J.S., Mick R., Stevenson J., Metz J., Zhu T., Buyske J., Sterman D.H., Pass H.I., Glatstein E., Hahn S.M. Ann. Thorac. Surg. 2003, 75(95):2-959.
7. Ma L., Moan J., Berg K. Int. J. Cancer 1994, 57:883-888.
8. Kiesslich T., Berlanda J., Plaetzer K., Krammer B., Berr F. Photochem. Photobiol. Sci. 2007, 6:619-627.
9. Sasnouski S., Zorin V., Khludeyev I., D'Hallewin M.A., Guillemin F., Bezdetnaya L. Biochim. Biophys. Acta 2005, 1725:394-402.
10. Biolitec Pharma Ltd. Foscan, summary of product characteristics.
11. Krueger T., Altermatt H.J., Mettler D., Scholl B., Magnusson L., Ris H.B. Lasers Surg. Med. 2003, 32:61-68.
12. Reuther T., Kubler A.C., Zillmann U., Flechtenmacher C., Sinn H. Lasers Surg. Med. 2001, 29:314-322.
13. Grahn M.F., Giger A., McGuinness A., de Jode M.L., Stewart J.C.M., Ris H.B., Altermatt H.J., Williams N.S. Lasers Med. Sci. 1999, 14:40-46.
14. Buchholz J., Kaser-Hotz B., Khan T., Rohrer Bley C., Melzer K., Schwendener R.A., Roos M., Walt H. Clin. Cancer Res. 2005, 11:7538-7544.
15. Pegaz B., Debefve E., Ballini J.P., Wagnieres G., Spaniol S., Albrecht V., Scheglmann D.V., Nifantiev N.E., van den Bergh H., Konan-Kouakou Y.N. Eur. J. Pharm. Sci. 2006, 28:134-140.
16. Torchilin V.P. J. Control. Release 2001, 73:137-172.
17. Gaucher G., Dufresne M.H., Sant V.P., Kang N., Maysinger D., Leroux J.C. J. Control. Release 2005, 109:169-188.
18. Kwon G.S., Okano T. Adv. Drug Deliv. Rev. 1996, 21(10):7-116.
19. Jones M.-C., Leroux J.-C. Eur. J. Pharm. Biopharm. 1999, 48:101-111.
20. Kwon G.S. Crit. Rev. Ther. Drug Carrier Syst. 2003, 20:357-403.